^
    over1year
    Pillar Biosciences Receives China National Medical Products Administration (NMPA) Approval for oncoReveal Dx Colon Cancer Assay (Pillar Biosciences Press Release)
    "Pillar Biosciences...announced that its oncoReveal Dx Colon Cancer Assay has received approval from the China National Medical Products Administration (NMPA). The IVD assay is now commercially available in China, the U.S., and Europe as a companion diagnostic (CDx) to identify patients with colorectal cancer whose tumors express wild-type KRAS status and may benefit from treatment with specific targeted therapies."
    Non-US regulatory
    |
    oncoReveal™ Dx Colon Cancer Assay